Laxmi Organic IPO GMP Today, Check Daily Movement

0

Last updated on March 22, 2021

It is surely raining IPOs for investors who have yet another opportunity in the form of Laxmi Organic Industries. The offer is priced in the range of INR129 – 130 per share and 35% of the shares will be reserved for small investors. A total sum of INR600 crore will be mobilized by the offer. Meanwhile, Laxmi Organic IPO GMP has started on a strong footing.

Laxmi Organic IPO details

Subscription Dates15 – 17 March 2021 
Price BandINR129 – 130 per share
Fresh issueINR300 crore
Offer For SaleINR300 crore    
Total IPO sizeINR600 crore
Minimum bid (lot size)115 shares
Face Value INR2 per share
Retail Allocation35%
Listing OnNSE, BSE

The offer price translates into a P/E ratio range of 45.10 – 45.45, based on FY2020 EPS. This may appear on the higher side but the market appears to like its decent margin and return ratios. In FY2020, its Return on Net Worth (RONW) stood at 16.45% while net profit margin was also at a robust 5.6% despite Covid-19 disruptions. Grey premium activity started at over 100% of offer price and even though it has come down lately, the rates are still near 50%, indicating bright prospects of listing gains.

Laxmi Organic IPO GMP (Grey Market Premium) rates

DateGMP (in INR)Kostak (in INR)Subject to Sauda (in INR)
22 Mar 2021603006,000
20 Mar 2021703506,000
19 Mar 2021904006,000
18 Mar 20211104506,500
17 Mar 2021904006,000
16 Mar 20211104506,500
15 Mar 20211304506,500
13 Mar 2021904006,000
12 Mar 2021904006,000
11 Mar 2021803505,500
10 Mar 20211104006,500
9 Mar 20211304007,000
8 Mar 2021150450 

Investors are likely to take stock of the several positive factors including customers in over 30 countries, 23% revenue contribution by exports, and presence of several customers such as Syngenta, Alembic Pharmaceuticals, Dr. Reddy’s Laboratories, Granules India, Huhtamaki India, Laurus Labs, Mylan Laboratories, Neuland Laboratories, and Suven Pharmaceuticals.  

Laxmi Organic’s financial performance (in INR crore)

 FY2018FY2019FY2020H1 FY2021
Revenue1,396.11,574.31,538.6814.4
Expenses1,282.81,476.31,483.5758.2
Net income76.072.369.745.6
Net margin (%)5.44.64.55.6

LEAVE A REPLY

Please enter your comment!
Please enter your name here